{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:31:36Z","timestamp":1791869496613,"version":"4.3.4"},"reference-count":143,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Rodents are commonly employed to model human liver conditions, although species differences can restrict their translational relevance. To overcome some of these limitations, researchers have long pursued human hepatocyte transplantation into rodents. More than 20 years ago, the first primary human hepatocyte transplantations into immunodeficient mice with liver injury were able to support hepatitis B and C virus infections, as these viruses cannot replicate in murine hepatocytes. Since then, hepatocyte chimeric mouse models have transitioned into mainstream preclinical research and are now employed in a diverse array of liver conditions beyond viral hepatitis, including malaria, drug metabolism, liver-targeting gene therapy, metabolic dysfunction-associated steatotic liver disease, lipoprotein and bile acid biology, and others. Concurrently, endeavors to cotransplant other cell types and humanize immune and other nonparenchymal compartments have seen growing success. Looking ahead, several challenges remain. These include enhancing immune functionality in mice doubly humanized with hepatocytes and immune systems, efficiently creating mice with genetically altered grafts and reliably humanizing chimeric mice with renewable cell sources such as patient-specific induced pluripotent stem cells. In conclusion, hepatocyte chimeric mice have evolved into vital preclinical models that address many limitations of traditional rodent models. Continued improvements may further expand their applications.<\/jats:p>","DOI":"10.1055\/s-0044-1790601","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:18:44Z","timestamp":1726168724000},"page":"405-415","source":"Crossref","is-referenced-by-count":8,"title":["Mice Engrafted with Human Liver Cells"],"prefix":"10.1055","volume":"44","author":[{"given":"Ype P.","family":"de Jong","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, New York"},{"name":"Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"05","key":"ref1","first-page":"771","article-title":"Isolation, culture, and transplantation of human hepatocytes","volume":"68","author":"S C Strom","year":"1982","journal-title":"J Natl Cancer Inst"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"M Dandri","year":"2001","journal-title":"Hepatology"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"D F Mercer","year":"2001","journal-title":"Nat Med"},{"issue":"23","key":"ref4","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.3390\/ijms21239289","article-title":"Advances in transgenic mouse models to study infections by human pathogenic viruses","volume":"21","author":"D Masemann","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"02","key":"ref5","first-page":"213","article-title":"Establishment of a cell line from a human fetal liver and its xenotransplantation to nude mice","volume":"71","author":"O Nakagomi","year":"1980","journal-title":"Gann"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0676.1991.tb00523.x","article-title":"Transplantation studies on human and duck hepatocytes in athymic nude mice","volume":"11","author":"M Hanawa-Shimizu","year":"1991","journal-title":"Liver"},{"issue":"06","key":"ref7","first-page":"3020","article-title":"Retroviral transduction of human hepatocytes and orthotopic engraftment in SCID mice after hepatocellular transplantation","volume":"24","author":"H E Soriano","year":"1992","journal-title":"Transplant Proc"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2007.11.012","article-title":"Chimeric mice with humanized liver","volume":"246","author":"M Katoh","year":"2008","journal-title":"Toxicology"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.177.1.191","article-title":"Homozygous scid\/scid;beige\/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation","volume":"177","author":"D E Mosier","year":"1993","journal-title":"J Exp Med"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","article-title":"Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment","volume":"154","author":"T Pearson","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ni1527","article-title":"Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells","volume":"8","author":"K Takenaka","year":"2007","journal-title":"Nat Immunol"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2012-06-440354","article-title":"Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment","volume":"121","author":"T Yamauchi","year":"2013","journal-title":"Blood"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.gastro.2015.05.043","article-title":"Fibroblast growth factor signaling controls liver size in mice with humanized livers","volume":"149","author":"W E Naugler","year":"2015","journal-title":"Gastroenterology"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional","volume":"405","author":"M Hasegawa","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbrc.2008.09.124","article-title":"Establishment of a humanized model of liver using NOD\/Shi-scid IL2Rg null mice","volume":"377","author":"H Suemizu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"100410","DOI":"10.1016\/j.dmpk.2021.100410","article-title":"An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals","volume":"42","author":"S Uehara","year":"2022","journal-title":"Drug Metab Pharmacokinet"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"e0119820","DOI":"10.1371\/journal.pone.0119820","article-title":"A novel mouse model for stable engraftment of a human immune system and human hepatocytes","volume":"10","author":"H Strick-Marchand","year":"2015","journal-title":"PLoS One"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1538\/expanim.17-0034","article-title":"Incidence of spontaneous lymphomas in non-experimental NOD\/Shi-scid, IL-2R\u03b3null (NOG) mice","volume":"66","author":"M Yasuda","year":"2017","journal-title":"Exp Anim"},{"issue":"254","key":"ref19","doi-asserted-by":"crossref","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"Y P de Jong","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4939-6506-9_6","article-title":"Propagation of human hepatocytes in uPA\/SCID mice: producing chimeric mice with humanized liver","volume":"1506","author":"H Ohshita","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhep.2010.03.024","article-title":"Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice","volume":"53","author":"T Vanwolleghem","year":"2010","journal-title":"J Hepatol"},{"issue":"05","key":"ref22","first-page":"1273","article-title":"Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes","volume":"151","author":"K Overturf","year":"1997","journal-title":"Am J Pathol"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/hep.21582","article-title":"Directed differentiation of human embryonic stem cells into functional hepatic cells","volume":"45","author":"J Cai","year":"2007","journal-title":"Hepatology"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"P Meuleman","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"e77298","DOI":"10.1371\/journal.pone.0077298","article-title":"Chimeric mouse model for the infection of hepatitis B and C viruses","volume":"8","author":"A Tesfaye","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"e0142145","DOI":"10.1371\/journal.pone.0142145","article-title":"Generation of novel chimeric mice with humanized livers by using hemizygous cDNA-uPA\/SCID mice","volume":"10","author":"C Tateno","year":"2015","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"M Grompe","year":"1993","journal-title":"Genes Dev"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"M Grompe","year":"1995","journal-title":"Nat Genet"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"H Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"51","key":"ref30","doi-asserted-by":"crossref","first-page":"20507","DOI":"10.1073\/pnas.0710528105","article-title":"Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model","volume":"104","author":"K D Bissig","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"K D Bissig","year":"2010","journal-title":"J Clin Invest"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2016.04.022","article-title":"Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells","volume":"65","author":"E Billerbeck","year":"2016","journal-title":"J Hepatol"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2353\/ajpath.2010.091154","article-title":"Liver xeno-repopulation with human hepatocytes in Fah-\/-Rag2-\/- mice after pharmacological immunosuppression","volume":"177","author":"Z He","year":"2010","journal-title":"Am J Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9636897211006132","DOI":"10.1177\/09636897211006132","article-title":"Sexual dimorphism in hepatocyte xenograft models","volume":"30","author":"G Sari","year":"2021","journal-title":"Cell Transplant"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2013.10.040","article-title":"A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections","volume":"441","author":"K Kosaka","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"M L Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-0716-0704-6_9","article-title":"Engraftment of human hepatocytes in the PiZ-NSG mouse model","volume":"2164","author":"Q Tang","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13287-015-0038-9","article-title":"Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK\/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities","volume":"6","author":"R R Zhang","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"27","key":"ref39","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.3748\/wjg.v23.i27.4935","article-title":"Human liver chimeric mouse model based on diphtheria toxin-induced liver injury","volume":"23","author":"X N Ren","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"08","key":"ref40","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/lt.22099","article-title":"Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model","volume":"16","author":"T Kawahara","year":"2010","journal-title":"Liver Transpl"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"111321","DOI":"10.1016\/j.celrep.2022.111321","article-title":"Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice","volume":"40","author":"M Kabbani","year":"2022","journal-title":"Cell Rep"},{"issue":"18","key":"ref42","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.cell.2023.07.017","article-title":"Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions","volume":"186","author":"E Kaffe","year":"2023","journal-title":"Cell"},{"issue":"7768","key":"ref43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"N Aizarani","year":"2019","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.omtm.2022.12.014","article-title":"Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution","volume":"28","author":"M Cabanes-Creus","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jhep.2023.11.020","article-title":"Comprehensive gene profiling of the metabolic landscape of humanized livers in mice","volume":"80","author":"C Jiang","year":"2024","journal-title":"J Hepatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-6506-9_8","article-title":"Successful engraftment of human hepatocytes in uPA-SCID and FRG\u00ae KO mice","volume":"1506","author":"L Foquet","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.510310126","article-title":"A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice","volume":"31","author":"J J Brown","year":"2000","journal-title":"Hepatology"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/73187","article-title":"Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses","volume":"6","author":"K Ohashi","year":"2000","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"L Allweiss","year":"2016","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coviro.2015.04.009","article-title":"Animal models for the study of HCV","volume":"13","author":"K Vercauteren","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/v13040588","article-title":"In vivo models of HDV infection: Is humanizing NTCP enough?","volume":"13","author":"K Giersch","year":"2021","journal-title":"Viruses"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"a031674","DOI":"10.1101\/cshperspect.a031674","article-title":"Murine models of hepatitis A virus infection","volume":"9","author":"A Hirai-Yuki","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"e2086","DOI":"10.1002\/rmv.2086","article-title":"Updates in hepatitis E virus (HEV) field; lessons learned from human liver chimeric mice","volume":"30","author":"I M Sayed","year":"2020","journal-title":"Rev Med Virol"},{"issue":"51","key":"ref54","doi-asserted-by":"crossref","first-page":"32648","DOI":"10.1073\/pnas.2014096117","article-title":"Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury","volume":"117","author":"A L Bailey","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mib.2018.09.003","article-title":"Rodent malaria models: insights into human disease and parasite biology","volume":"46","author":"M De Niz","year":"2018","journal-title":"Curr Opin Microbiol"},{"issue":"6347","key":"ref56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.aal1962","article-title":"Mouse models of acute and chronic hepacivirus infection","volume":"357","author":"E Billerbeck","year":"2017","journal-title":"Science"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijpara.2005.10.014","article-title":"Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers","volume":"36","author":"J B Sacci Jr","year":"2006","journal-title":"Int J Parasitol"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1172\/JCI62684","article-title":"Complete Plasmodium falciparum liver-stage development in liver-chimeric mice","volume":"122","author":"A M Vaughan","year":"2012","journal-title":"J Clin Invest"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1038\/ncomms8690","article-title":"Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice","volume":"6","author":"V Soulard","year":"2015","journal-title":"Nat Commun"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","article-title":"Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice","volume":"17","author":"S A Mikolajczak","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"08","key":"ref61","doi-asserted-by":"crossref","first-page":"101381","DOI":"10.1016\/j.isci.2020.101381","article-title":"A humanized mouse model for Plasmodium vivax to test interventions that block liver stage to blood stage transition and blood stage infection","volume":"23","author":"C Sch\u00e4fer","year":"2020","journal-title":"iScience"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"M Martignoni","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drudis.2008.11.009","article-title":"The future of drug safety testing: expanding the view and narrowing the focus","volume":"14","author":"J L Stevens","year":"2009","journal-title":"Drug Discov Today"},{"issue":"09","key":"ref64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/00498250500296231","article-title":"In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver","volume":"35","author":"M Katoh","year":"2005","journal-title":"Xenobiotica"},{"issue":"06","key":"ref65","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/dmd.104.002600","article-title":"In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver","volume":"33","author":"M Katoh","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"C Tateno","year":"2004","journal-title":"Am J Pathol"},{"issue":"12","key":"ref67","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1124\/dmd.104.001347","article-title":"Expression of human cytochromes P450 in chimeric mice with humanized liver","volume":"32","author":"M Katoh","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"02","key":"ref68","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/toxsci\/kfm041","article-title":"Humanization of excretory pathway in chimeric mice with humanized liver","volume":"97","author":"H Okumura","year":"2007","journal-title":"Toxicol Sci"},{"issue":"12","key":"ref69","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1124\/dmd.109.028183","article-title":"The uPA(+\/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione","volume":"37","author":"L Lootens","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.112.198697","article-title":"Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction","volume":"344","author":"T Nishimura","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/FPC.0b013e32835cb2c7","article-title":"Human pharmacogenetic analysis in chimeric mice with \u2018humanized livers\u2019","volume":"23","author":"Y Hu","year":"2013","journal-title":"Pharmacogenet Genomics"},{"issue":"18","key":"ref72","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/rcm.6673","article-title":"In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200","volume":"27","author":"N De Brabanter","year":"2013","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"11","key":"ref73","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.109.031732","article-title":"Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver","volume":"38","author":"R Kikuchi","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/j.gastro.2007.07.007","article-title":"Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse","volume":"133","author":"T Vanwolleghem","year":"2007","journal-title":"Gastroenterology"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1038\/s41598-022-19242-0","article-title":"Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism","volume":"12","author":"S Uehara","year":"2022","journal-title":"Sci Rep"},{"issue":"05","key":"ref76","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/HEP.0000000000000631","article-title":"Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation","volume":"79","author":"A Vonada","year":"2024","journal-title":"Hepatology"},{"issue":"7488","key":"ref77","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"L Lisowski","year":"2014","journal-title":"Nature"},{"issue":"21","key":"ref78","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","article-title":"Multiyear factor VIII expression after AAV gene transfer for hemophilia A","volume":"385","author":"L A George","year":"2021","journal-title":"N Engl J Med"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymthe.2017.09.021","article-title":"Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity","volume":"26","author":"N K Paulk","year":"2018","journal-title":"Mol Ther"},{"issue":"22","key":"ref80","doi-asserted-by":"crossref","first-page":"e131610","DOI":"10.1172\/jci.insight.131610","article-title":"Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors","volume":"4","author":"K Pekrun","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"ref81","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41434-019-0104-5","article-title":"Superior human hepatocyte transduction with adeno-associated virus vector serotype 7","volume":"26","author":"W Shao","year":"2019","journal-title":"Gene Ther"},{"issue":"12","key":"ref82","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/mt.2015.179","article-title":"Comparative study of liver gene transfer with AAV vectors based on natural and engineered AAV capsids","volume":"23","author":"L Wang","year":"2015","journal-title":"Mol Ther"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/hum.2022.176","article-title":"Characterization of a bioengineered AAV3B capsid variant with enhanced hepatocyte tropism and immune evasion","volume":"34","author":"J Rana","year":"2023","journal-title":"Hum Gene Ther"},{"issue":"06","key":"ref84","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/mt.2016.61","article-title":"Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid","volume":"24","author":"K Vercauteren","year":"2016","journal-title":"Mol Ther"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1038\/ncomms8339","article-title":"Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model","volume":"6","author":"B Bissig-Choisat","year":"2015","journal-title":"Nat Commun"},{"issue":"03","key":"ref86","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.32733","article-title":"Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy","volume":"77","author":"N Meumann","year":"2023","journal-title":"Hepatology"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/s41467-024-46017-0","article-title":"A humanized mouse model for adeno-associated viral gene therapy","volume":"15","author":"M Barzi","year":"2024","journal-title":"Nat Commun"},{"issue":"05","key":"ref88","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/ATVBAHA.116.307227","article-title":"CRISPR-Cas9 targeting of PCSK9 in human hepatocytes in vivo-brief report","volume":"36","author":"X Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2020.11.014","article-title":"CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice","volume":"20","author":"D Stone","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"03","key":"ref90","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","article-title":"Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles","volume":"17","author":"M ZC Hatit","year":"2022","journal-title":"Nat Nanotechnol"},{"issue":"04","key":"ref91","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Z M Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000899","article-title":"Alcohol-associated liver disease-Global epidemiology","author":"F \u00c5berg","year":"2024","journal-title":"Hepatology"},{"issue":"06","key":"ref93","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"M E Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"05","key":"ref94","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"G Farrell","year":"2019","journal-title":"Hepatology"},{"issue":"06","key":"ref95","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"M Vacca","year":"2024","journal-title":"Nat Metab"},{"issue":"04","key":"ref96","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1210\/en.2010-0953","article-title":"Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver","volume":"152","author":"C Tateno","year":"2011","journal-title":"Endocrinology"},{"issue":"05","key":"ref97","doi-asserted-by":"crossref","first-page":"e0268260","DOI":"10.1371\/journal.pone.0268260","article-title":"Insights from a high-fat diet fed mouse model with a humanized liver","volume":"17","author":"R Saxena","year":"2022","journal-title":"PLoS One"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1038\/s41598-024-53890-8","article-title":"Multi-omics analysis of a fatty liver model using human hepatocyte chimeric mice","volume":"14","author":"A Ichikawa","year":"2024","journal-title":"Sci Rep"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"101165","DOI":"10.1016\/j.omtm.2023.101165","article-title":"Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers","volume":"31","author":"X Wang","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"15","key":"ref100","doi-asserted-by":"crossref","first-page":"eadf4490","DOI":"10.1126\/sciadv.adf4490","article-title":"IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models","volume":"9","author":"M Carbonaro","year":"2023","journal-title":"Sci Adv"},{"issue":"03","key":"ref101","doi-asserted-by":"crossref","first-page":"100281","DOI":"10.1016\/j.jhepr.2021.100281","article-title":"A human liver chimeric mouse model for non-alcoholic fatty liver disease","volume":"3","author":"B Bissig-Choisat","year":"2021","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"08","key":"ref102","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"P K Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"issue":"02","key":"ref103","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jcmgh.2021.10.007","article-title":"A novel humanized model of NASH and its treatment with META4, a potent agonist of MET","volume":"13","author":"J Ma","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"ref104","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"11","key":"ref105","doi-asserted-by":"crossref","first-page":"e78550","DOI":"10.1371\/journal.pone.0078550","article-title":"Mice with chimeric livers are an improved model for human lipoprotein metabolism","volume":"8","author":"E C Ellis","year":"2013","journal-title":"PLoS One"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbrc.2020.01.067","article-title":"A mouse model of humanized liver shows a human-like lipid profile, but does not form atherosclerotic plaque after western type diet","volume":"524","author":"G Sari","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"02","key":"ref107","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.31052","article-title":"Insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans","volume":"72","author":"M E Minniti","year":"2020","journal-title":"Hepatology"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1194\/jlr.M081935","article-title":"FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver","volume":"59","author":"R Papazyan","year":"2018","journal-title":"J Lipid Res"},{"issue":"03","key":"ref109","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcmgh.2017.07.002","article-title":"Analysis of hepatitis C virus particle heterogeneity in immunodeficient human liver chimeric fah-\/- mice","volume":"4","author":"U Andreo","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.116.236935","article-title":"Disrupted murine gut-to-human liver signaling alters bile acid homeostasis in humanized mouse liver models","volume":"360","author":"E C Chow","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"ref111","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1124\/dmd.123.001398","article-title":"Analysis of the bile acid composition in a fibroblast growth factor 19-expressing liver-humanized mouse model and its use for CYP3A4-mediated drug-drug interaction studies","volume":"51","author":"M Mezler","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00335-019-09796-2","article-title":"Humanized mouse models of immunological diseases and precision medicine","volume":"30","author":"L D Shultz","year":"2019","journal-title":"Mamm Genome"},{"key":"ref113","first-page":"53","article-title":"NOD\/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models","volume":"324","author":"M Ito","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajpath.2013.09.008","article-title":"Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice","volume":"184","author":"T L Gutti","year":"2014","journal-title":"Am J Pathol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"E M Wilson","year":"2014","journal-title":"Stem Cell Res"},{"issue":"6533","key":"ref116","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.abe2485","article-title":"Combined liver-cytokine humanization comes to the rescue of circulating human red blood cells","volume":"371","author":"Y Song","year":"2021","journal-title":"Science"},{"issue":"6531","key":"ref117","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aaz6964","article-title":"Cholangiocyte organoids can repair bile ducts after transplantation in the human liver","volume":"371","author":"F Sampaziotis","year":"2021","journal-title":"Science"},{"issue":"10","key":"ref118","doi-asserted-by":"crossref","first-page":"e77255","DOI":"10.1371\/journal.pone.0077255","article-title":"Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice","volume":"8","author":"M E Fomin","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"ref119","doi-asserted-by":"crossref","first-page":"170108","DOI":"10.1098\/rsob.170108","article-title":"Human fetal liver cultures support multiple cell lineages that can engraft immunodeficient mice","volume":"7","author":"M E Fomin","year":"2017","journal-title":"Open Biol"},{"issue":"05","key":"ref120","doi-asserted-by":"crossref","first-page":"101023","DOI":"10.1016\/j.jhepr.2024.101023","article-title":"Liver specification of human iPSC-derived endothelial cells transplanted into mouse liver","volume":"6","author":"K K Yap","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"04","key":"ref121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis B functional cure","volume":"20","author":"S G Lim","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"ref122","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41575-019-0196-9","article-title":"Restoring, releasing or replacing adaptive immunity in chronic hepatitis B","volume":"16","author":"M K Maini","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"03","key":"ref123","doi-asserted-by":"crossref","first-page":"e1004032","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"M T Bility","year":"2014","journal-title":"PLoS Pathog"},{"issue":"06","key":"ref124","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1053\/j.gastro.2017.08.034","article-title":"Viral load affects the immune response to HBV in mice with humanized immune system and liver","volume":"153","author":"M Duss\u00e9aux","year":"2017","journal-title":"Gastroenterology"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"898615","DOI":"10.3389\/fimmu.2022.898615","article-title":"Animal models for autoimmune hepatitis: Are current models good enough?","volume":"13","author":"U Christen","year":"2022","journal-title":"Front Immunol"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"J Chuprin","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/ten.tea.2015.0427","article-title":"Primary human hepatocytes repopulate livers of mice after in vitro culturing and lentiviral-mediated gene transfer","volume":"22","author":"J Bierwolf","year":"2016","journal-title":"Tissue Eng Part A"},{"issue":"03","key":"ref128","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1073\/pnas.1919035117","article-title":"Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes","volume":"117","author":"E Michailidis","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7859","key":"ref129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"K Musunuru","year":"2021","journal-title":"Nature"},{"issue":"05","key":"ref130","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ymthe.2021.01.024","article-title":"Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes","volume":"29","author":"M Zabulica","year":"2021","journal-title":"Mol Ther"},{"issue":"01","key":"ref131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.gastro.2011.10.029","article-title":"Frequent aneuploidy among normal human hepatocytes","volume":"142","author":"A W Duncan","year":"2012","journal-title":"Gastroenterology"},{"issue":"06","key":"ref132","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","article-title":"Long-term expansion of functional mouse and human hepatocytes as 3D organoids","volume":"175","author":"H Hu","year":"2018","journal-title":"Cell"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells","volume":"51","author":"K Si-Tayeb","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"ref134","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3727\/096368913X673432","article-title":"Enabling autologous human liver regeneration with differentiated adipocyte stem cells","volume":"23","author":"D Xu","year":"2014","journal-title":"Cell Transplant"},{"issue":"7494","key":"ref135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature13020","article-title":"Mouse liver repopulation with hepatocytes generated from human fibroblasts","volume":"508","author":"S Zhu","year":"2014","journal-title":"Nature"},{"issue":"03","key":"ref136","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","article-title":"Direct reprogramming of human fibroblasts to functional and expandable hepatocytes","volume":"14","author":"P Huang","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"03","key":"ref137","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stem.2014.01.008","article-title":"Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming","volume":"14","author":"Y Du","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"7369","key":"ref138","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature10424","article-title":"Targeted gene correction of \u03b11-antitrypsin deficiency in induced pluripotent stem cells","volume":"478","author":"K Yusa","year":"2011","journal-title":"Nature"},{"issue":"11","key":"ref139","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1172\/JCI75456","article-title":"Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model","volume":"124","author":"A Carpentier","year":"2014","journal-title":"J Clin Invest"},{"issue":"03","key":"ref140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00595-020-02092-6","article-title":"Current status of hepatocyte-like cell therapy from stem cells","volume":"51","author":"Y Saito","year":"2021","journal-title":"Surg Today"},{"issue":"02","key":"ref141","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.31705","article-title":"Advanced techniques and awaited clinical applications for human pluripotent stem cell differentiation into hepatocytes","volume":"74","author":"E Luce","year":"2021","journal-title":"Hepatology"},{"issue":"05","key":"ref142","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1053\/j.gastro.2018.01.066","article-title":"Biotechnology challenges to in vitro maturation of hepatic stem cells","volume":"154","author":"C Chen","year":"2018","journal-title":"Gastroenterology"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/pr.2017.284","article-title":"Human hepatocyte transplantation for liver disease: current status and future perspectives","volume":"83","author":"V Iansante","year":"2018","journal-title":"Pediatr Res"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1790601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T18:35:58Z","timestamp":1733337358000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1790601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":143,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,12,4]]},"published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1790601","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}